United States· US:0338-1015_25553ed1-2375-4bb9-96ec-13f54e0af857
OXACILLIN
A oxacillin product containing oxacillin sodium, registered in United States by Baxter Healthcare Corporation. The same ATC class is registered in 5 of our 19 countries.
Checked against FDA National Drug Code directory (United States) on
Informational only — not a medical device.
Where it is registered
Oxacillin is registered in 5 of 19 countries.
Countries holding a registration under ATC J01CF04 (oxacillin), each read from that country’s own register.
- This record: United States, from FDA National Drug Code directory (United States)
- 5 of them publish a price we can compare per daily dose
Oxacillin · ATC J01CF04
5 / 19 countries
- Belgiumprice
- Czechiaprice
- Franceprice
- Polandprice
- United Statesprice
The record
At a glance
FDA National Drug Code directory (United States)- Active substance
- OXACILLIN SODIUM
- Manufacturer
- Baxter Healthcare Corporation
- Country
- United States (US)
- ATC code
- J01CF04
- ATC class
- Oxacillin
- Defined daily dose
- 2 g, O
- Reimbursed
- Not published by this register
- Source register
- FDA National Drug Code directory (United States)
- Last checked
- September 27, 2026
Packs & prices · 1
- ndc110338-1015-41
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
59 interactions on record for oxacillin.
Graded by severity as the source publishes them — 3 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Oxacillin · interactions on record
59 records
- 3 severe
- 16 moderate
- 4 minor
- 36 info
Most severe, free to view
- MethotrexateL01BA01severe
- MethotrexateL04AX03severe
- MethotrexatM01CX01severe
- Sodium picosulfateA06AB08moderate
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Oxacillin in 5 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- CzechiaOXACILIN AVMCAV Medical CZ s.r.o., Praha
- FranceISTOPEN 1 g/5 ml, poudre et solvant pour solution injectable (IV)LABORATOIRES DELBERT
- BelgiumPenstapho Injection 1 gBristol-Myers Squibb Belgium
- ItalyPENSTAPHO*1 fiala IM EV 1 g + 1 fiala solvLABORATOIRES DELBERT
- PolandOxacilin NoramedaNorameda UAB
Authorised across Europe · EMA
The same active substance is authorised in 8 EEA countries. Names it is sold under:
- Czechia · Oxacilin Avmc, Prostaphlin
- Estonia · Oxacillin Auxilia
- France · Istopen, Oxacilline Panpharma
- Italy · Oxciva, Penstapho
- Latvia · Oxacillin Pan
- Poland · Oxacilin Norameda
- Romania · Oxacilina Arena, Oxacilina Atb
- Slovakia · Oxacilin Avmc
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/f5528117-c825-4281-ba1c-c60ada0972fd GET /v1/drugs/f5528117-c825-4281-ba1c-c60ada0972fd?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"route": "INTRAVENOUS",
"source": "ndc",
"strength": "2",
"substance": "OXACILLIN SODIUM",
"productndc": "0338-1015",
"dosage_form": "INJECTION, SOLUTION",
"dea_schedule": null,
"strength_unit": "g/50mL",
"application_number": "NDA050640",
"marketing_category": "NDA"
}See everything about oxacillin.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.